We are live on ! Find out more
NMRD

Nemaura Medical, Inc. Common Stock
NMRD

Delisted

NMRD was delisted on the 4th of January, 2024.

Back to rankings

1 hedge funds and large institutions have $13K invested in Nemaura Medical, Inc. Common Stock in 2019 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

80% less funds holding

Funds holding: 5 → 1 (-4)

87% less capital invested

Capital invested by funds: $97K → $13K (-$84K)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 4

Holders
1
Holders Change
-4
Holders Change %
-80%
% of All Funds
0.02%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
-$36K
2
Deutsche Bank
Deutsche Bank
Germany
-$35K
3
UBS Group
UBS Group
Switzerland
-$11K
4
CFGS
Concourse Financial Group Securities
Alabama
-$1.97K
Name Holding Trade Value Shares
Change 		Change in
Stake
SC
1
Scotia Capital
Ontario, Canada
$13K – – –
Deutsche Bank
2
Deutsche Bank
Germany
– -$35K -3,464 Closed
Renaissance Technologies
3
Renaissance Technologies
New York
– -$36K -3,464 Closed
UBS Group
4
UBS Group
Switzerland
– -$11K -1,046 Closed
CFGS
5
Concourse Financial Group Securities
Alabama
– -$1.97K -208 Closed

NMRD Hedge Fund Activity: Q2 2019 in Review

1 of the 4,604 institutional investors tracked by Wall St. Rank reported a position in Nemaura Medical, Inc. Common Stock (NMRD) for Q2 2019, worth a combined $13K — down 87% from $97K a quarter earlier.

Sellers outnumbered buyers: 4 funds closed out of NMRD and 0 opened new positions — a net loss of 4 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Renaissance Technologies, exiting entirely with an estimated $36K sold.

  • 1 institutional investor held Nemaura Medical, Inc. Common Stock (NMRD) as of Q2 2019, down from 5 in Q1 2019.
  • Funds reported $13K of Nemaura Medical, Inc. Common Stock stock for Q2 2019, down 87% quarter-over-quarter.
  • 0 funds opened new Nemaura Medical, Inc. Common Stock positions in Q2 2019 and 4 closed out, a net change of -4 holders.
  • The largest Nemaura Medical, Inc. Common Stock seller in Q2 2019 was Renaissance Technologies, an estimated $36K sold.

Based on aggregated 13F filings for Q2 2019.